Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept

J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S122-6. doi: 10.1016/j.jaad.2005.11.1089.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Arthritis, Rheumatoid / epidemiology*
  • Comorbidity
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Middle Aged
  • Prednisone / administration & dosage
  • Receptors, Tumor Necrosis Factor / antagonists & inhibitors
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Recurrence
  • Sweet Syndrome / drug therapy*
  • Sweet Syndrome / epidemiology*

Substances

  • Anti-Inflammatory Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept
  • Prednisone